Operating EBITDA stood at INR 436 Cr, +18% YoY PAT for the quarter grew by +27% YoY to INR 291 Cr Gross Revenue stood at INR 1,719 Cr for Q1 FY24, +17% growth YoY & +5% growth QoQ Network Operating EBITDA was INR 436 Cr, growth
With COVID-19 cases coming down in the country, the government on Friday removed export curbs on all diagnostic kits and reagents including instruments, which are used in detection of coronavirus infections. India logged 16,862 new coronavirus infections, taking the total tally of COVID-19 cases to
India’s COVID-19 infection tally crossed 55 lakh on Tuesday, while a record 1,01,468 patients recovered in a day, taking their number to 44,97,867 and pushing the recovery rate to 80.86 per cent, the Union health ministry data showed. The coronavirus caseload in the country surged to
India saw a single-day rise of 36,083 new coronavirus infections, raising its tally to 3,21,92,576, while the death toll has climbed to 4,31,225 with 493 fresh fatalities, according to the Union Health Ministry data updated on Sunday. The active cases have declined to 3,85,336 and comprise 1.20 percent of the
The Union health ministry on Monday reiterated there is no scientific evidence of COVID-19 vaccination causing infertility in men and women and asserted the jabs are safe and effective. There have been media reports expressing concern regarding infertility due to COVID-19 vaccination among people of reproductive
Airbus on Wednesday airlifted oxygen concentrators and ventilators from Toulouse in France to Delhi amid the second wave of the COVID-19 pandemic, its statement said. The items brought from France on Wednesday were part of the consignment that was delivered to the NGO Indian Red
Union Health Minister Harsh Vardhan, whose tenure as the WHO Executive Board chairperson ended on Wednesday, called for ensuring affordable access to key drugs during crises like the coronavirus pandemic and advocated a shared and collaborative response to conquer future health challenges. Vardhan addressed the 149th Session
Vaccine, being a biological product, takes time for harvesting and quality testing and this cannot be done overnight to ensure a safe product, the Union Health Ministry said on Friday. The ministry said Government of India, through the National Expert Group on Vaccine Administration for COVID-19